Skip to main content
OpenTrials
Completed

NCT Number: NCT03527940

Prognostic Markers of Patients With STEMI

To analyze the relationship between the clinical data and the outcomes of STEMI patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

STEMI - ST Elevation Myocardial Infarction Cardiovascular Diseases Heart Diseases Infarction Ischemia Myocardial Infarction Myocardial Ischemia Necrosis Pathologic Processes Pathological Conditions, Signs and Symptoms ST Elevation Myocardial Infarction Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

The First Affiliated Hospital of Chongqing Medical University

Chongqing, Chongqing Municipality, 400000, China

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients diagnosed with ST-segment elevation myocardial infarction(STEMI).

Exclusion criteria

  • Patients with concurrent infection or any documented inflammatory illness, such as arthritis or connective tissue diseases,or any other malignancy.
  • Pregnant women.
  • Severe hepatic dysfunction.
  • Uncontrolled hypertension.

Treatment and study plan

Primary outcomes

  1. All cause mortality

    Time frame: 3 years

Sponsors and collaborators

Lead sponsor

Chongqing Medical University

Other

Registry information

Official study title

Prognostic Markers of Patients With ST-segment Elevation Myocardial Infarction

Important dates

Study start
2015
Primary completion
2019
Study completion
2020
First posted
May 17, 2018
Registry last updated
Mar 4, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.